Immune monitoring for advanced cell therapy trials in transplantation: which assays and when?
A number of immune regulatory cellular therapies, including regulatory T cells and mesenchymal stromal cells, have emerged as novel alternative therapies for the control of transplant alloresponses. Clinical studies have demonstrated their feasibility and safety, however developing our understanding...
Main Authors: | Stark, HL, Wang, HC, Kuburic, J, Alzhrani, A, Hester, J, Issa, F |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Frontiers Media
2021
|
Similar Items
-
An exploration of regulatory T cells in transplantation: cell therapy development and immune monitoring
by: Alzhrani, AI
Published: (2021) -
Feasibility, long‐term safety and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients
by: Harden, PN, et al.
Published: (2020) -
Biomarkers and surrogates of acute rejection in vascularized composite allograft transplantation
by: Honeyman, C, et al.
Published: (2021) -
Towards regulatory cellular therapies in solid organ transplantation
by: Bottomley, MJ, et al.
Published: (2021) -
Biomarker and surrogate development in vascularised composite allograft transplantation: current progress and future challenges
by: Honeyman, C, et al.
Published: (2020)